Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. EBITDA 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2011 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Sonoma Pharmaceuticals Inc. ebitda for the quarter ending June 30, 2025 was -1.1 M, a 6.61% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. ebitda for the twelve months ending June 30, 2025 was -4.2 M, a 36.12% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. annual ebitda for 2025 was -3.6 M, a 21.06% decrease from 2024.
- Sonoma Pharmaceuticals Inc. annual ebitda for 2024 was -4.5 M, a 1.80% increase from 2023.
- Sonoma Pharmaceuticals Inc. annual ebitda for 2023 was -4.4 M, a 22.03% decrease from 2022.
- Sonoma Pharmaceuticals Inc. annual ebitda for 2022 was -5.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sonoma Pharmaceuticals Inc. EBITDA — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) ebitda over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNOA's ebitda history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.